Petra Rietschel

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Ahmet Sezer, Mahmut Gümüş, Igor Bondarenko et al. · The Lancet · 2021 · 772 citations

Radiology, Medicine, Bronchial Neoplasm +9

Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy

Colleen Hadigan, James B. Meigs, Colleen Corcoran et al. · Clinical Infectious Diseases · 2001 · 678 citations

Obesity, Metabolic Syndrome, Body Composition +13

Variates of Survival in Metastatic Uveal Melanoma

Petra Rietschel, Katherine S. Panageas, Christine Hanlon et al. · Journal of Clinical Oncology · 2005 · 310 citations · Full text

Assessment of Growth Hormone Dynamics in Human Immunodeficiency Virus-Related Lipodystrophy1

Petra Rietschel, Colleen Hadigan, Colleen Corcoran et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 292 citations · Full text

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial

Miranda Gogishvili, Tamar Melkadze, Tamta Makharadze et al. · Nature Medicine · 2022 · 268 citations · Full text